Novavax
NVAX
#5751
Rank
C$1.55 B
Marketcap
C$9.55
Share price
0.73%
Change (1 day)
-17.97%
Change (1 year)

Novavax (NVAX) - Total assets

Total assets on the balance sheet as of September 2025 : C$1.63 Billion

According to Novavax's latest financial reports the company's total assets are C$1.63 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Novavax - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31C$2.23 B-6.08%
2023-12-31C$2.38 B-22.21%
2022-12-31C$3.06 B-6.67%
2021-12-31C$3.28 B62.75%
2020-12-31C$2.01 B793.25%
2019-12-31C$0.22 B-20.27%
2018-12-31C$0.28 B-25.51%
2017-12-31C$0.38 B-28.23%
2016-12-31C$0.52 B-1.05%
2015-12-31C$0.53 B67.19%
2014-12-31C$0.32 B27.97%
2013-12-31C$0.25 B145.93%
2012-12-31C$0.10 B50.28%
2011-12-31C$67.72 M-9.48%
2010-12-31C$74.81 M-16.94%
2009-12-31C$90.07 M-3.32%
2008-12-31C$93.16 M2.3%
2007-12-31C$91.07 M-35.82%
2006-12-31C$0.14 B44.44%
2005-12-31C$98.24 M4.87%
2004-12-31C$93.67 M-14.19%
2003-12-31C$0.10 B20.2%
2002-12-31C$90.82 M-15.05%
2001-12-31C$0.10 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Agenus
AGEN
C$0.32 B-80.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
C$4.82 B 196.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$2.01 B 23.83%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
C$0.61 B-62.16%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$158.12 B 9,600.57%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
C$288.36 B 17,590.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$148.21 B 8,993.14%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NanoViricides
NNVC
C$12.19 M-99.25%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$113.91 B 6,888.82%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
C$0.89 B-45.04%๐Ÿ‡บ๐Ÿ‡ธ USA